Carol Ashe

Carol Ashe

Director/Board Member at ELICIO THERAPEUTICS, INC.

Net worth: - $ as of 30/05/2026

68 year
Health Technology
Consumer Services
Finance

Profile

Carol G.
Ashe
currently works at Elicio Therapeutics, Inc. (United States), as Independent Director from 2020, Elicio Therapeutics, Inc., as Independent Director from 2020, and New York Genome Center, as Chief Business Officer from 2014.
Ms. Ashe also formerly worked at Aptose Biosciences, Inc., as Independent Director from 2018 to 2025, Endo International Plc, as Vice President-Corporate Development from 2011 to 2013, GSK Equity Investments Ltd, as Partner from 2009 to 2010, and GSK Plc, as Head-US Corporate Legal Group from 2007 to 2008.
Ms. Ashe received her undergraduate degree from The Pennsylvania State University and graduate degree from Villanova University School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
08/04/2026 0 ( -.--% ) - $ 30/05/2026

Carol Ashe active positions

CompaniesPositionStart
ELICIO THERAPEUTICS, INC. Director/Board Member 31/07/2020
Corporate Officer/Principal 31/12/2013
Director/Board Member 31/12/2019

Former positions of Carol Ashe

CompaniesPositionEnd
APTOSE BIOSCIENCES INC. Director/Board Member 15/06/2025
ENDO INTERNATIONAL PLC Corporate Officer/Principal 31/12/2012
Private Equity Investor 29/03/2010
GSK PLC Corporate Officer/Principal 31/12/2007
See the detail of Carol Ashe's experience

Training of Carol Ashe

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!